Biography
Dr. Peng Lu is a Ph.D. graduate in Public Health and Preventive Medicine from Nanjing Medical University. With a long-standing focus on tuberculosis research, Dr. Peng Lu specializes in areas such as drug-resistant tuberculosis, latent tuberculosis infection, and the immunology of tuberculosis. Throughout his career, he has contributed significantly to the understanding of these critical public health issues and are dedicated to advancing research aimed at improving diagnosis, treatment, and prevention strategies for tuberculosis.
Key Impacts
Integrated machine learning and proteomic profiling reveal host-specific response proteins as predictive biomarkers for TB diagnosis
This study establishes a novel 10-protein biomarker panel that accurately predicts TB progression risk through machine learning-enhanced proteomic profiling. The high diagnostic performance suggests clinical utility for risk-stratifying LTBI populations, potentially reducing unnecessary chemoprophylaxis by 83% based on specificity estimates. Future multi-center validation and mechanistic studies on the ACTR3-mediated immune-stromal crosstalk could enable targeted interception of TB progression.
Source: Conference 2024
Prediction of TB risk in the elderly population of Eastern China: Development and validation of multiple machine learning models
This study successfully developed and validated multiple machine learning models to predict TB risk in the elderly of Eastern China. The LassoCox model showed moderate predictive accuracy for TB risk in the elderly. However, limited survival curve separation suggests the need for additional predictors, higher event rates, and advanced modeling to enhance risk stratification and clinical utility.
Source: Conference 2024